Obese women with polycystic ovary syndrome (PCOS) often suffer from ovulation failure, which may be driven by granulosa cells (GCs) injury caused by increased levels of circulating oxidized low-density lipoprotein (ox-LDL) and luteinizing hormone (LH). PGC-1α may play an important role in this pathophysiological processes. However, the effect and the potential mechanism of PGC-1α on GCs injury evoked by obese PCOS is fully unclear. To investigate the protective effect and the potential mechanism of PGC-1α on GCs injury evoked by ox-LDL + LH stimulation. Patients with PCOS and women of normal reproductive age who undergoing egg retrievals and consenting for this research were collected. Those women were divided into normal-weight non-PCOS group, obese non-PCOS group, normal-weight PCOS group and obese PCOS group according to the body mass index (BMI) and PCOS diagnosis. Follicular fluid was collected and primary GCs were isolated. The levels of LH and ox-LDL in follicular fluid in the four groups were measured. And, the expressions of PGC-1α, cell apoptosis and ROS generation in primary GCs in the four groups were evaluated. After GCs from women of normal reproductive age at normal-weight pre-treated with adenovirus encoding PGC-1α (Ad-PGC-1α) prior to ox-LDL + LH treatment in vitro, the cell viability, apoptosis, apoptosis-related proteins expressions and ROS generation were evaluated by CCK-8 assay, AnnexinV/PI double staining, Western blot and H2DCF-DA staining, respectively. The expression of PGC-1α was significantly decreased, whereas the cell apoptosis and ROS generation were significantly increased in GCs of PCOS group, especially obese PCOS group. Our data also revealed that over-expression of PGC-1α in GCs from women of normal reproductive age at normal-weight markedly inhibited cell injury, ROS generation and p38 activation, accompanied by increased Bcl-2 expression, decreased Bax and cleaved caspase-3 expressions induced by ox-LDL + LH stimulation. Ox-LDL + LH-induced cell apoptosis was abrogated by attenuation of ROS generation or p38 activation. Attenuation of ROS generation reversed ox-LDL + LH-induced p38 activation, however, p38 inhibitors had an effect on ROS generation. Our findings suggested that PGC-1α protected against ox-LDL + LH-induced GCs injury through inhibiting cell apoptosis. And, the mechanism may be related to the inhibition of ROS-initiated p38 pathway. Our data indicated that PGC-1α may be a potential therapeutic target for obese PCOS.
This is a preview of subscription content, log in to check access.
YL carried out the study, data statistics and drafted the manuscript; JZ supervised the study and the data statistics; JC participated in study design and the data statistics; XW and TW participated in scientific discussion of the data.
Compliance with ethical standards
Conflict of interest
The authors have declared that no competing interests exist.
All the subjects undergoing egg retrievals and consenting for this research, and all the clinical data were collected with the consent of the subjects and their family members and signed the relevant informed consent. Moreover, the experimental design was approved by the Committee for Ethics of Beijing Tongren Hospital.
This study is approved by all authors for publication.
Prathap A, Subhalakshmi TP, Varghese PJ. A cross-sectional study on the proportion of anxiety and depression and determinants of quality of life in polycystic ovarian disease. Indian J Psychol Med. 2018;40(3):257–62.CrossRefGoogle Scholar
Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19–25.CrossRefGoogle Scholar
Bilal M, Haseeb A, Rehman A. Relationship of polycystic ovarian syndrome with cardiovascular risk factors. Diabetes Metab Syndr. 2018;12(3):375–80.CrossRefGoogle Scholar
Azziz R, Carmina E, Chen Z, et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016;2:16057.CrossRefGoogle Scholar
Zhang Y, Liu H, He J, et al. Lactonase activity and status of paraoxonase 1 in Chinese women with polycystic ovarian syndrome. Eur J Endocrinol. 2015;172(4):391–402.CrossRefGoogle Scholar
Ruderman NB, Carling D, Prentki M, Cacicedo JM. AMPK, insulin resistance, and the metabolic syndrome. J Clin Investig. 2013;123(7):2764–72.CrossRefGoogle Scholar
Wang N, Luo LL, Xu JJ, et al. Obesity accelerates ovarian follicle development and follicle loss in rats. Metabolism. 2014;63(1):94–103.CrossRefGoogle Scholar
Zheng Q, Li Y, Zhang D, et al. ANP promotes proliferation and inhibits apoptosis of ovarian granulosa cells by NPRA/PGRMC1/EGFR complex and improves ovary functions of PCOS rats. Cell Death Dis. 2017;8(10):e3145.CrossRefGoogle Scholar
Cui X, Jing X, Wu X, et al. Abnormal expression levels of BMP15/Smad1 are associated with granulosa cell apoptosis in patients with polycystic ovary syndrome. Mol Med Rep. 2017;16(6):8231–6.CrossRefGoogle Scholar
Victor VM, Rovira-Llopis S, Bañuls C, et al. Insulin resistance in PCOS patients enhances oxidative stress and leukocyte adhesion: role of myeloperoxidase. PLoS One. 2016;11(3):e0151960.CrossRefGoogle Scholar
Villena JA. New insights into PGC-1 coactivators: redefining their role in the regulation of mitochondrial function and beyond. FEBS J. 2015;282(4):647–72.CrossRefGoogle Scholar
Nijland PG, Witte ME, van het Hof B, et al. Astroglial PGC-1alpha increases mitochondrial antioxidant capacity and suppresses inflammation: implications for multiple sclerosis. Acta Neuropathol Commun. 2014;2:170.CrossRefGoogle Scholar
Zhang G, Wan Y, Zhang Y, et al. Expression of mitochondria-associated genes (PPARGC1A, NRF-1, BCL-2 and BAX) in follicular development and atresia of goat ovaries. Reprod Domest Anim. 2015;50(3):465–73.CrossRefGoogle Scholar
Zhang GM, Deng MT, Zhang YL, et al. Effect of PGC-1α overexpression or silencing on mitochondrial apoptosis of goat luteinized granulosa cells. J Bioenergy Biomembr. 2016;48(5):493–507.CrossRefGoogle Scholar
Aghadavod E, Zarghami N, Farzadi L, et al. Isolation of granulosa cells from follicular fluid; applications in biomedical and molecular biology experiments. Adv Biomed Res. 2015;4:250.CrossRefGoogle Scholar
Zhang M, Harashima N, Moritani T, Huang W, Harada M. The roles of ROS and caspases in TRAIL-induced apoptosis and necroptosis in human pancreatic cancer cells. PLoS One. 2015;10(5):e0127386.CrossRefGoogle Scholar
Düzgün ŞA, Yerlikaya A, Zeren S, Bayhan Z, Okur E, Boyacı İ. Differential effects of p38 MAP kinase inhibitors SB203580 and SB202190 on growth and migration of human MDA-MB-231 cancer cell line. Cytotechnology. 2017;69(4):711–24.CrossRefGoogle Scholar
Li Q, Bao F, Zhi D, et al. Lipopolysaccharide induces SBD-1 expression via the P38 MAPK signaling pathway in ovine oviduct epithelial cells. Lipids Health Dis. 2016;15(1):127.CrossRefGoogle Scholar
Wallberg F, Tenev T, Meier P. Analysis of apoptosis and necroptosis by fluorescence-activated cell sorting. Cold Spring Harb Protoc. 2016;2016(4):pdb.prot087387.CrossRefGoogle Scholar
Zhang Z, Ren Z, Chen S, et al. ROS generation and JNK activation contribute to 4-methoxy-TEMPO-induced cytotoxicity, autophagy, and DNA damage in HepG2 cells. Arch Toxicol. 2018;92(2):717–28.CrossRefGoogle Scholar
Xu H, Sun F, Li X, Sun L. Down-regulation of miR-23a inhibits high glucose-induced EMT and renal fibrogenesis by up-regulation of SnoN. Hum Cell. 2018;31(1):22–32.CrossRefGoogle Scholar
González-Fernández R, Hernández J, Martín-Vasallo P, Puopolo M, Palumbo A, Ávila J. Expression levels of the oxidative stress response gene ALDH3A2 in granulosa-lutein cells are related to female age and infertility diagnosis. Reprod Sci. 2016;23(5):604–9.CrossRefGoogle Scholar
Qi S, Feng Z, Li Q, Qi Z, Zhang Y. Inhibition of ROS-mediated activation Src-MAPK/AKT signaling by orient in alleviates H2O2-induced apoptosis in PC12 cells. Drug Des Dev Ther. 2018;12:3973–84.CrossRefGoogle Scholar
Zhu J, Yu W, Liu B, et al. Escin induces caspase-dependent apoptosis and autophagy through the ROS/p38 MAPK signalling pathway in human osteosarcoma cells in vitro and in vivo. Cell Death Dis. 2017;8(10):e3113.CrossRefGoogle Scholar
Bañuls C, Rovira-Llopis S, Martinez de Marañon A, et al. Metabolic syndrome enhances endoplasmic reticulum, oxidative stress and leukocyte-endothelium interactions in PCOS. Metabolism. 2017;71:153–62.CrossRefGoogle Scholar
Zhang Y, Liu L, Yin TL, Yang J, Xiong CL. Follicular metabolic changes and effects on oocyte quality in polycystic ovary syndrome patients. Oncotarget. 2017;8(46):80472–80.Google Scholar
Hyderali BN, Mala K. Oxidative stress and cardiovascular complications in polycystic ovarian syndrome. Eur J Obstet Gynecol Reprod Biol. 2015;191:15–22.CrossRefGoogle Scholar
Lai Q, Xiang W, Li Q, et al. Oxidative stress in granulosa cells contributes to poor oocyte quality and IVF-ET outcomes in women with polycystic ovary syndrome. Front Med. 2018;12(5):518–24.CrossRefGoogle Scholar
Hu J, Lang Y, Zhang T, Ni S, Lu H. Lentivirus-mediated PGC-1α overexpression protects against traumatic spinal cord injury in rats. Neuroscience. 2016;328:40–9.CrossRefGoogle Scholar
Rahmani E, Samimi M, Ebrahimi FA, et al. The effects of omega-3 fatty acids and vitamin E co-supplementation on gene expression of lipoprotein(a) and oxidized low-density lipoprotein, lipid profiles and biomarkers of oxidative stress in patients with polycystic ovary syndrome. Mol Cell Endocrinol. 2017;439:247–55.CrossRefGoogle Scholar
Zhang D, Luo WY, Liao H, Wang CF, Sun Y. The effects of oxidative stress to PCOS. Sichuan Da Xue Xue Bao Yi Xue Ban. 2008;39(3):421–3.Google Scholar
Ma HL, Gao JS, Tian F, Ng EHY, Wu XK, Liu JP. Effect of letrozole, berberine, or their combination for infertility in women with polycystic ovary syndrome: statistical analysis plan for a multicenter randomized controlled trial. World J Tradit Chin Med. 2016;2(3):36–42.Google Scholar
Ling XM, Zhang XH, Tan Y, et al. Protective effects of oviductus ranae-containing serum on oxidative stress-induced apoptosis in rat ovarian granulosa cells. J Ethnopharmacol. 2017;208:138–48.CrossRefGoogle Scholar